Table 1 |
|
|
Demographic and clinical characteristics |
|
| Variable |
Value (n = 115) |
|
|
|
| Females |
108 (93.9) |
| Limited cutaneous systemic sclerosis |
84 (73) |
| Autoantibody |
|
| Antinuclear antibody without specific pattern |
19 (16.5) |
| Anticentromere antibody |
44 (38.3) |
| Antitopoisomerase I antibody |
50 (43.5) |
| Age at onset (years) |
43.4 ± 12.6 |
| Mean follow-up (years) |
14.6 ± 8.7 |
| Forced viral capacity <70% predicted |
27 (23.4) |
| Diffusing capacity for carbon monoxide <70% predicted |
82 (71.4) |
| Right systolic ventricular pressure ≥ 40 mmHg |
22 (19.1) |
| Oesophageal involvement |
110 (96.2) |
| Past history of digital ulcers |
63 (54.7) |
|
|
|
|
Data presented as n (%) or as the mean ± standard deviation. |
|
|
Beretta et al. Arthritis Research & Therapy 2008 10:R103 doi:10.1186/ar2495 |
|
